Radiofrequency Catheter Ablation. Radiofrequency catheter ablation techniques are becoming increasingly accepted as the therapy of choice for selected patients with symptomatic arrhythmias. The ability to titrate the power output using radiofrequency current has allowed these ablative techniques to be applied safely in a variety of arrhythmias. In many institutions, radiofrequency catheter ablation has now become standard therapy for controlling medically refractory atrial arrhythmias using atrioventricular (AV) junction ablation and for curing AV nodal reentrant tachycardia and supraventricular tachycardia due to accessory AV Connections. This technology is also being used to treat some forms of ventricular tachycardia such as bundle branch reentry ventricular tachycardia, ventricular tachycardia in structurally normal hearts, and with limited success in patients with ventricular tachycardia and coronary artery disease. Advancements in catheter design and energy delivery systems may further expand the use of this form of
Introduction
Percutaneous transvenous catheter ablation of myocardial tissue has been used since the early 1980s for treatment of supraventricular and ventricular arrhythmias.'-^ High-voltage direct current pulses from a standard defibrillator were used as the first ablative energy source. Although effective, the use of direct current shocks is associated with significant limitations, including the need for general anesthesia, and the risk of serious barotraumiatic side effects."
Energy produced by alternating current in the radiofrequency range has been used in electrosurgery for over 50 years. Radiofrequency current applied via needles has been used to create discrete lesions in the central and peripheral nervous systems^'^ and for adjuvant thermotberapy of malignancies.Ŝ tudies in animals suggested that percutaneous radiofrequency catheter ablation could be used safely to create discrete lesions in the atria, ventricles, and atrioventricular (AV) junction.^-'Ŝ ubsequent reports as early as 1987 showed that radiofrequency ablation was safe and effective in humans and this has been corroborated in several recent larger series.'''' ^ in a number of institutions, radiofrequency catheter ablation has now supplanted surgical ablation for definitive cure of the Wolff-Parkinson-White syndrome and paroxysmal supraventricular tachycardia due to AV nodal reentry, and will likely become the standard of care for the nonpharmacologic management of these Manuscript received 15 October 1991; Accepted for publication 11 December 1991.
The Biophysics of Radiofrequency Lesion Formation
Radiofrequency refers to alternating current in tbe range of 0.1 to 100 MHz. When used for ablation of cardiac arrhythmias, continuous, unmodulated sine wave outputs in the range of 100 to 750 kHz are used. This is distinctly different from the waveform used for electrosurgical cutting and coagulation, where high-voltage, short duration pulses with a long duty cycle are designed to promote arcing or coagulum formation (Fig. 1 ).
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Figure 1. Wxveforms used for radiofrequency cardiac catheter ablation (A) and for electrosurgery (B). Energy used for cardiac ablation is applied as a continuous, unmodulated sine wave of approximately 500 kHz. Outputs are typically in the range of 40-60 volts (V). In contrast, cutting and coagulation waveforms from electrosurgical units are much higher voltages and applied as a series of short pulses.
The mechanism of lesion formation by radiofrequency energy is via thermal injury to the tissue.^ The heating of cells drives water from them, leading to desiccation and coagulative necrosis, which occurs at a temperature of approximately 48 °C.'^'^^ During catheter ablation, current flows from the catheter electrode tip to the tissue, resulting in acceleration of ions and resistive heating of the electrode-tissue interface. Since the power density falls off exponentially as a fimction of distance from the electrode, only a small rim of tissue around the catheter tip is heated directly by the current. The majority of thermal injury is mediated by conduction of heat away from the area of electrode contact into the surrounding tissue (Fig. 2) . Therefore, the temperature gradient seen during radiofrequency ablation is accurately modeled as a heat source with a diameter only slightly larger than the ablating electrode. Provided the duration of energy application is adequate to achieve a steady state, lesion size can be predicted by electrode diameter and tip temperature.^^ Lesion size is limited by the fact that tip temperatures above 100 °C result in coagulum formation that coats the ablating electrode. This insulates the electrode, causing an abrupt rise in impedance that limits current flow and prevents further lesion expan- 
Radiofrequency Energy Delivery Parameters
The magnitude of high-voltage shocks used for catheter ablation is usually estimated by the energy stored in the defibrillator capacitors. Since the duration of current flow is extremely brief, there is some correlation between stored energy, peak voltage, and biological effects.
The mechanism of radiofrequency lesion formation is completely different. With onset of current flow, the temperature at the electrode-tissue interface increases over a period of 10-40 seconds until the energy applied via the ablation catheter equals tn^t lost through conduction and convection of heat away from the site.'^ Once a steady-state temperature gradient has been achieved, there is no further lesion expansion. Based on this model, total delivered energy (power X duration) would be expected to correlate with lesion volume only during the early growth phase, but not with applications of longer duration.'Ŝ tudies of radiofrequency lesion formation in vitro show better a correlation between applied power, duration of application, total energy, and resultant lesion size than comparable studies in vivo.'^-2' This most likely reflects the multitude of variables that can influence temperature at the electrode surface, including contact pressure, current density, and convective heat loss via intracavitary blood
Radiofrequency Power Supply Design
Several characteristics of a lesion generation system are necessary for safe and effective operation. Output that can be varied between 10 and 40 watts (W) is required. As in all medical electronics, the device must be electrically isolated to prevent the possibility of leakage current producing arrhythmias or injury. Output parameters (voltage, current, or power) must be monitored to allow detection of an impedance rise due to coagulum formation on the ablating electrode. Continued energy application after impedance rise may result in charring and excessive heating with the possibility of catheter disruption.^2 Electrophysiologic recording systems have widely varying susceptibility to interference during ablation. Adequate filtering must be used to allow continuous monitoring of the surface electrocardiogram (ECG) during energy application.
Radiofrequency Ablation Catheter Design
A number of studies have examined the relationship between electrode configuration and radiofrequency lesion characteristics. Active fixation electrodes result in bigger lesions in vitro than do similar-sized passive contact electrodes,^'' presumably because of the larger surface area in direct contact with the myocardium.
The effect of electrode size on lesion volume in vivo was examined in our laboratory.^"* The results of radiofrequency application using a standard 6 French electrode catheter were compared to those using catheters modified with longer distal electrodes. Increasing electrode length from 2 to 4 mm more than doubled mean lesion volume from 143 to 326 mm^ at the same applied power. Increasing electrode length beyond 4 mm produced progressively smaller lesions, either because of a lower power density or as the result of contact between the proximal portion of the electrode and the blood pool.
Other studies have shown that cooling of the distal electrode with saline infused via a central lumen may delay or prevent the occurrence of coagulum formation and impedance rise, allowing larger maximal lesion size to be achieved.^^-^^C linical Application of Radiofrequency Catheter Ablation
Ablation ofthe Atrioventricular Junction
Huang and co-workers^^ described the use of radiofrequency catheter ablation for production of complete AV block in experimental animals. They were able to achieve complete AV block in over 80% of the animals. The safety and efficacy of this technique has been corroborated by other investigators as well.Ê arly experience in patients undergoing radiofrequency catheter ablation of the AV junction was characterized by modest success rates of approximately 50%-60% without significant complications or mortality.^^-^^ Jackman et al.'2 achieved a higher success rate with conventional electrode catheters, but required an increased number of energy applications.
The introduction of large-tipped (3-4 mm in length) steerable ablation catheters has dramatically improved success rates from approximately 60% to greater than 90%, decreased the incidence of impedance rise due to coagulum formation, and decreased the number of applications required to achieve AV block.'^-'^Using the large tip electrode, Langberg et al.^*' were able to achieve complete AV block in 12 of 13 patients using a mean of 18 ± 6 W of power and 7 ± 5 applications. Jackman et al. also demonstrated the superiority of the large tip electrode for AV junction ablation. With the use of the large tip electrode they achieved complete AV block in 10 of 10 patients versus 6 of 7 patients with the small tip electrode. Compared to the small tip electrode, the large tip achieved complete AV block with fewer radiofrequency applications (4.7 ± 4.6 vs 42 ± 22), and allowed delivery of greater power (33 ± 13.0 W vs 10.2 ± 0.6 W) without coagulum formation.'^ Currently in our laboratory, we use 30-35 W of power delivered for 30-60 seconds when complete AV block is desired.
Patients who fail radiofrequency ablation may still be successfully treated with high-voltage, direct current shock ablation. An innovative technique to produce block using radiofrequency lesions applied to the mitral annulus has recently been described.^' Sousa et al. found this to be successful in 8 of 8 patients who had failed attempts at ablation of the AV junction from the right side. The ablation catheter is advanced into the femoral artery and then passed retrogradely across the aortic valve to the left ventricle where it is positioned against the septal aspect of the mitral annulus at a site with the largest His electrogram amplitude. Radiofrequency current is then applied at an output of 20-36 W for up to 60 seconds. Using this technique when ablation from the right side is ineffective has obviated the need for direct current shock ablation of the JW junction in our laboratory.
In order to successfully interrupt conduction with radiofrequency applied to the tricuspid annulus, the ablation catheter must be positioned more proximally than during a diagnostic electrophysiologic test. An "ideal" site is one where an atrial:ventricular electrogram ratio is > 1 and a large (> 150 /iV) His electrogram can be recorded. Application to the site ofthe largest His electrogram will often be too distal, resulting in right bundle block rather than complete AV block. Several studies suggest that the occurrence of an accelerated junctional rhythm during energy application is a sensitive but nonspecific indication of an effective site.^'*^^ Our approach is to discontinue radiofrequency energy application and reposition the catheter if no junctional ectopy or change in conduction is observed after 20 seconds.
Target sites typically have an atrial:ventricular electrogram ratio > 1 and a small (< 100 /iV) His electrogram. Radiofrequency energy is applied until there is approximately 50% prolongation of the PR interval or a nonconducted P wave is observed. Junctional tachycardia often occurs during ablation and atrial overdrive pacing may be required to allow continuous assessment of conduction. After ablation, there is prolongation of the atrial (A) to His bundle (H) interval, usually without a change in the antegrade Wenckebach cycle length or effective refractory period. Retrograde conduction is eliminated in approximately 40% of patients. The remainder have marked attenuation of retrograde conduction, with prolongation of the retrograde Wenckebach cycle length and ventriculoatrial conduction time (Fig. 4) . AV nodal function curves after ablation appear similar to the slow pathway portion of the curve before the procedure. All these changes post-ablation are consistent with selective ablation of the fast JW nodal pathway.^2. 13, 42, 43 Using this approach, success rates of 82% and 95% were achieved in two large series. However, inadvertent complete AV block occurred in 8% and 2% of patients, respectively.'^-'* We have Radiofrequency Catheter Ablation for Treatment of AV Nodal Reentrant Tachycardia
Over the last decade, surgical ablation has been shown to be a safe and efficacious therapy for drug refractory AV nodal reentry.^^''''*Intraoperatively, either cryothermia or electrophysiologically-guided sharp dissection is used around the proximal AV junction. These techniques have been able to eliminate reentry while still preserving antegrade conduction. Initial experience with radiofrequency ablation to produce variable degrees of AV block in animals suggested that the safety and titratibility of this energy source would make it well suited for treatment of AV nodal reentry.^^"^^ Early reports on small series of patients confirmed that radiofrequency catheter ablation could be used to eliminate reentry with preservation of conduction. [38] [39] [40] [41] Two different approaches to radiofrequency catheter modification of AV nodal reentrant tachycardia are now being used. The first technique developed was one where lesions are applied slightly anterior and proximal to the site of the maximal His electrogram'^''* (Fig. 3) . recently modified our technique in an attempt to decrease the risk of high-grade AV block. Initially, ablation of the target site began with relatively high power (> 15 W) and the duration of the application was used to titrate the electrophysiologic effect. We now begin radiofrequency application at each new site at a power of 10 W for up to 20 seconds. If no effect is seen, power is increased in increments of 5 W with each 20-second test application until the desired effect is achieved or up to a maximum of 30 W. By titration of applied power and duration, we have avoided inadvertent AV block in a consecutive series of 32 patients.
An exciting altemative approach to radiofrequency modification of AV nodal reentrant tachycardia has been developed using lesions applied near the ostium of the coronary sinus aimed at destroying the slow AV nodal pathway. This "posterior approach" is attractive because ablative injury occurs distant from the distal AV junction and His bundle, and it appears that the risk of high-grade AV block may be less. The target site for this technique has an atrial: ventricular electrogram ratio of approximately 1:2. A high-frequency deflection after the offset of the atrial electrogram also appears to be a sensitive but nonspecific indicator of an effective site (Fig. 5) . As with ablative lesions made anteriorly, radiofrequency energy applied to an effective site posteriorly is often associated with junctional tachycardia. Lesions made in this area appear to selectively affect slow AV nodal pathway function. After ablation, there is no change in the A-H interval or in retrograde conduction or refractoriness. There may be slight prolongation of the antegrade Wenckebach cycle length and effective refractory period.
Roman et al.,"* in a preliminary report, described elimination of slow pathway function in 12 of 13 patients. In an ongoing, prospective comparison of the two techniques of AV nodal modification, our success rate with the posterior approach is approximately 60%. Larger studies are needed to defme the safety and efficacy of the posterior approach. Since elimination of slow pathway function preserves a normal PR interval and may obviate the risk of high-grade block, the posterior approach may become the technique of choice, with crossover to the anterior approach only if the slow pathway cannot be successfully ablated.
The ability to selectively damage different parts of the reentrant loop has greatly contributed to our understanding of the pathogenesis of typical AV nodal reentrant tachycardia. It is now clear that two anatomically distinct inputs to the distal AV node form the antegrade and retrograde limbs of the circuit. The ability to selectively eliminate slow or fast pathway conduction at widely disparate sites argues strongly against functional longitudinal dissociation within the node itself as the mechanism of reentry. We have observed new "atypical" AV nodal reentry after successftil fast pathway AV nodal modification . "^^ This arrhythmia occurred in 11 % of patients treated with anterior lesions and was characterized by an RP > PR interval and was induced exclusively with ventricular pacing during isoproterenol infusion. This arrhythmia most likely resulted from an increase in fast pathway refractoriness without complete elimination of fast pathway function. Although none of the patients were treated, only one had an episode of spontaneous atypical tachycardia during follow-up.
Radiofrequency Ablation of Accessory Pathways
The use of radiofrequency catheter ablation to destroy extranodal accessory AV connections is one of the most significant recent advances in arrhythmia management (Fig. 6) . In many institutions, catheter ablation has largely replaced arrhythmia surgery for definitive treatment of patients with the Wolff-Parkinson-White syndrome.'**-'' Techniques used to position the ablation catheter vary according to the location of the accessory pathway. Left-sided pathways are usually ablated using a catheter in the left ventricle. The electrode catheter is introduced into the femoral artery and passed retrograde across the aortic valve into the left ventricle. It is then manipulated between the mitral leaflet and ventricular endocardium and advanced to the level of the annulus where radiofrequency current is applied (Fig. 7) . The ablation catheter can often be placed in the left atrium using this approach and may then be withdrawn to the level of the annulus with lesions applied on the atrial surface at the base of the mitral leaflet.
A transseptal approach has also been used to ablate left-sided accessory pathways with radiofrequency energy.''^ After transseptal puncture, the electrode catheter is introduced into the left atrium through the transseptal sheath. Manipulation of the sheath and the steerable electrode catheter facilitates positioning and stability on the atrial side of the mitral annulus. At our institution, this approach is reserved for patients who have failed attempts using the retrograde aortic approach.
Femoral venous access is most often used for ablation of septal and right free-wall accessory pathways. The catheter is positioned on the atrial side of the tricuspid annulus. Occasionally, venous access from above (either intemal jugular or subclavian) may be helpful for catheter placement on the tricuspid annulus. This is particularly useful for pathways located in the anterior and anterolateral areas. Although posteroseptal accessory pathways are most often ablated with lesions applied to the endocardium from the right side, some are interrupted with lesions made at or just inside the ostium of the coronary sinus or from the left ventricle using the retrograde aortic approach.''Â study by Wang et al.^^ evaluated the energy requirements necessary for successful ablation of accessory pathways. They found that at a power output of 30 W, a pulse duration of > 12 seconds was required to create block lasting longer than 30 minutes in the accessory pathway. Another important observation from this study was that if block did not occur within the first 4 seconds of radiofrequency current application, it was unlJLkely to result in permanent block. At our institution we usually deliver radiofrequency current at a power output of 30-36 W for a 5-to 10-second test application. If the test application is unsuccessful, the catheter is repositioned. If the test application results in loss of accessory pathway conduction, then the radiofrequency current is then delivered for an additional 30-60 seconds. is used to estimate electrode placement relative to the annulus. We have recently evaluated ablation site electrograms in an attempt to identify predictors of efficacy.'*^ During ablation of both concealed and manifest accessory pathways, electrogram stability (defined as < 10% change in amplitude with successive beats) was found to be an important determinant of success. Radiofrequency current applied at unstable sites had less than a 10% chance of success. During ablation of manifest accessory pathways mapped during sinus rhythm, a short interval between the local ventricular activation and the onset of the QRS was also predictive, as was the presence of a high-frequency deflection between the atrial and ventricular components of the signal suggestive of an accessory pathway potential (Fig. 8) . During ablation of concealed pathways or pathways mapped during orthodromic reciprocating tachycardia, an accessory pathway potential and the presence of continuous retrograde electrical activity (no isoelectric interval between the ventricular and atrial components of the signal) were significantly correlated with a successful ablation (Fig. 9) . Two large series of patients with accessory pathways treated with radiofrequency catheter ablation have recently been described.''''^ Jackman and co-workers'^ were successful in eliminating accessory pathway conduction in 164 of 166 patients (99%). Because of recurrence, two sessions were required in 15 patients (9%). Complications occurred in only five patients: pericarditis (1), cardiac tamponade (1), complete AV block (I), and pseudoaneurysm formation at the site of femoral arterial access (2). Calkins and co-workers'* were able to eliminate accessory pathway function in 51 of 56 (91 %) patients with 4 (15%) requiring two sessions. One patient sustained a myocardial infarction due to inadvertent application of radiofrequency energy within the circumfiex coronary artery.
Accessory pathway conduction may sometimes return after initially successful radiofrequency catheter ablation. We recently characterized the incidence and clinical features of accessory pathway recurrence in a series of 130 patients followed for a minimum of 3 months.^°A ccessory pathway conduction returned in 16 of 130 (12%) patients. Almost half (7/16) of these recurrences were within the first 12 hours after ablation and the latest one occurred after 106 days. Return of delta waves on ECG or spontaneous paroxysmal supraventricular tachycardia were the initial indications of recurrence in 15 of 16 patients. Two patients with manifest accessory pathways recurred with exclusively retrograde accessory pathway conduction.
Accessory pathways ablated from the tricuspid annulus (right free wall or septal accessory pathways) had a much higher recurrence rate (24%) than those on the mitral annulus (6%). Fourteen of 15 patients have had successful repeat accessory pathway ablation after the initial recurrence. Jackman et al.'^ described recurrence in 15 of 106 (9%) patients with initially successful accessory pathway ablation. The last of these occurred 4.7 months after the procedure. As with our study, there was a disproportionally higher incidence of recurrence among right-sided and septal pathways (14%) compared with left-sided accessory pathways (5%). Jackman and coworkers also noted a high efficacy rate of a second ablation session with all 15 of the patients with recurrent accessory pathway function having a successful second session.
Ablation of Ventricular Tachycardia
The use of radiofrequency current as an energy source for catheter ablation of ventricular tachycardia was first reported in 1987.*' In this early report, 3 of 5 patients with ventricular tachycardia were successfully treated with a mean follow-up of 7 months. Subsequent preliminary reports have indicated that radiofrequency current may be used successfully to treat ventricular tachycardia associated with coronary artery disease, arrhythmogenic right ventricular dysplasia, and structurally normal hearts.^'"^^ Another study by Kunze et al.^" did not find radiofrequency catheter ablation to be effective in patients with ventricular tachycardia. In this study, radiofrequency ablation was attempted in seven patients with ventricular tachycardia. Six had coronary artery disease and one patient had right ventricular outfiow tract tachycardia with a structurally normal heart. Radiofrequency energy was applied at 30 to 40 volts for 10 to 30 seconds without success; follow-up direct current electric shock ablation at the same site was successful in all cases. The relatively low power (< 20 W) used in this study may have contributed to the inefficacy. Because of the variable results in small series of patients, the role of radiofrequency catheter ablation for the treatment of microreentrant ventricular tachycardia remains to be defmed.
Radiofrequency catheter ablation appears ideally suited for treatment of ventricular tachycardia due to bundle branch reentry. Bundle branch reentry may be the cause of ventricular tachycardia in 15%-30% of patients with dilated cardiomyopathy from either ischemic or nonischemic causes.^^ The tachycardia usually has a left bundle branch block configuration and is mediated by antegrade conduction over the right bundle and retrograde conduction via the left bundle. Tchou et al.^^ showed that this type of ventricular tachycardia could be effectively treated with direct current shock ablation of the right bundle branch. Radiofrequency energy may also be used to treat bundle branch reentry (Fig.  10 ). Early case reports have shown that it is a safe and effective means of eliminating conduction over the right bundle and, therefore, eliminating the macroreentrant circuit causing bundle branch reentry. ^^'Â preliminary report has also found that radiofrequency energy may be effective in treating idiopathic ventricular tachycardia arising from the right ventricular outflow tract.^^ In this study, 3 of 3 patients were treated effectively using a mean power output of 36 W. No patient had a recurrence at a follow-up of 1 to 3 months. Idiopathic ventricular tachycardia arising from the left ventricle has also been treated effectively using radiofrequency energy. Two preliminary reports, each with one patient, reported successfill ablation after applying radiofrequency current to the site of earliest activation during ventricular tachycardia, which was located in the posteroseptal region in the left ventricle in both cases.^^-T rends for the Future Although efficacy rates for radiofrequency catheter ablation of AV nodal reentry and accessory pathway tachycardias exceeds 90% at experienced laboratories, procedure durations and fluoroscopy times remain high. Continued improvement in the design of ablation catheters promises to shorten and simplify the process. An increasing variety of steerable shaft configurations will undoubtedly facilitate radiofrequency ablation. To have catheters with a range of radii of curvature (as with angiographic catheters) will speed the process of mapping and increase the stability of contact at the ablation site.
Because many variables affect the amount of heating during radiofrequency ablation, energy delivery parameters correlate poorly with lesion volume. The ability to monitor temperature at the electrode-tissue interface using thermometry probes in the distal electrode will provide a more direct indication of the local effects of any given radiofrequency application. This will allow the differentiation between inadequate heating and inadequate positioning as the cause for lack of efficacy of any given radiofrequency application.^' The operator will be able to adjust power output to achieve a target temperature, thereby optimizing lesion volume while minimizing the risk of boiling, coagulum formation, and impedance rise.'R
egulatory Issues
Technological and clinical advances in interventional electrophysiology have occurred extremely rapidly. Although radiofrequency catheter ablation is considered the treatment of choice for definitive management of paroxysmal supraventricular tachycardia in selected patients, there is currentiy no catheter or power supply approved by the Food and Drug Administration for intracardiac use. As a result, the procedure is considered investigational by most institutions. Many insurance carriers, as well as the Health Care Finance Administration, do not reimburse for catheter ablation.
One manufacturer has begun a clinical trial of a radiofrequency ablation system and others will likely follow. Indications for the use of catheter ablation have been published^^ and guidelines for training personnel and facilities needed to perform ablation are being prepared. These regulatory efforts are of paramount importance to ensure that the rapid dissemination of the technique does not compromise the remarkable track record of safety reported to date.
